Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SUN-131 TDS for Chalazion
NCT03248440Phase 3Completed
- Sponsor
- Senju Pharmaceutical Co., Ltd.
- Start
- Jul 2017
- Primary completion
- Aug 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of SUN-131 in chalazion, sponsored by Senju Pharmaceutical Co., Ltd.. Started Jul 2017; status: completed.
02
Drugs
SUN-131
03
Conditions
chalazion
Beyond the preview
Go deeper on NCT03248440.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03248440.